Skip to main content

Day: April 29, 2024

Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals

THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats has provided notice of his retirement as chief executive officer and as a member of its board of directors, in each case effective July 7, 2024, his 10th anniversary with the company. The board of directors has initiated a search for a new chief executive officer which will consider both internal and external candidates. “During Mr. Coats’ tenure, Lexicon advanced two compounds through clinical development and into market, multiple programs into late-stage development and numerous compounds from discovery into development”, said Ray Debbane, the chair of Lexicon’s board of directors. “It is under his leadership that Lexicon transformed from a scientific platform company into a fully integrated biopharmaceutical...

Continue reading

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024

CONCORD, NC, April 29, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended March 31, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-end financial reporting processes, reviews, audit, and potential adjustments, each of which could result in changes to the numbers reported. “We’re pleased with the results Hydromer achieved in Q1 2024, demonstrating both our commitment to profitability and our strategic growth initiatives. Our journey...

Continue reading

FAT Brands to Announce First Quarter 2024 Financial Results On May 1, 2024

LOS ANGELES, April 29, 2024 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”), a leading global franchising company and parent company of iconic brands including Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, Fazoli’s and 13 other restaurant concepts, today announced that the Company will host a conference call to review its first quarter 2024 financial results on Wednesday, May 1, 2024 at 5:00 PM ET. A press release with first quarter 2024 financial results will be issued prior to the conference call that day. The conference call can be accessed live over the phone by dialing 1-844-826-3035 from the U.S. or 1-412-317-5195 internationally. A replay will be available after the call until Wednesday, May 22, 2024, and can be accessed by dialing 1-844-512-2921 from...

Continue reading

Edible Garden Begins Shipping ‘Garden Starters’ in Time for Spring Planting Season

Potted Herbs and Basil Bowls Available for Home Gardening Enthusiasts Sustainably driven Edible Garden Heartland facility in Grand Rapids, Michigan to manage the entire production, packaging, and distribution process Strategic use of backhauls and leveraging Edible Garden Heartland can significantly reduce CO2 emissions BELVIDERE, NJ, April 29, 2024 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that shipping of Garden Starters, a featured display for the Company’s potted herbs and basil bowls that can be planted in a consumer’s home garden, has begun to retail locations across the Midwest, beginning with Meijer. Mr. Jim Kras, Chief Executive...

Continue reading

Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET

HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.  Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.  Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here. Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.  About Harvard Bioscience  Harvard Bioscience, Inc. is a leading...

Continue reading

Scorpius Holdings Provides 2023 Year-End Business Update; Reports 570% Sequential Increase in Revenue for the Fourth Quarter of 2023

DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX) (‘Scorpius” or “the Company”), an integrated contract development and manufacturing organization providing state-of-the-art large molecule contract development and manufacturing organization (“CDMO”), today provided strategic, financial, and operational updates for the year ended December 31, 2023. Jeff Wolf, CEO of Scorpius Holdings, Inc., stated, “We are executing our plan to augment sales and drive revenue, as evidenced by the $4.8 million of revenue from continuing operations that we reported in the fourth quarter of 2023. This represents a 570% increase from the third quarter of 2023, and a 226% increase compared to revenue for the first nine months of the year. To date, Scorpius’s successful business development efforts have resulted...

Continue reading

California BanCorp Reports Financial Results for the First Quarter Ended March 31, 2024

OAKLAND, Calif., April 29, 2024 (GLOBE NEWSWIRE) — California BanCorp (NASDAQ: CALB) (the “Company”), whose subsidiary is California Bank of Commerce, announced today its financial results for the first quarter ended March 31, 2024. The Company reported net income of $3.8 million for the first quarter of 2024, representing a decrease of $1.5 million, or 29%, compared to $5.3 million for the fourth quarter of 2023 and a decrease of $1.6 million, or 30%, compared to $5.4 million in the first quarter of 2023. Excluding the impact of merger related expenses pertaining to the pending transaction with Southern California Bancorp, the Company’s net income for the first quarter of 2024 was $4.8 million (See Interim Consolidated Non-GAAP Data).        Diluted earnings per share were $0.45 for the first quarter of 2024, compared to $0.63...

Continue reading

Alto Ingredients, Inc. to Release First Quarter 2024 Financial Results on May 6, 2024

PEKIN, Ill., April 29, 2024 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel and essential ingredients and the largest producer of specialty alcohols in the United States, announced it will release its first quarter 2024 financial results after the close of market on Monday, May 6, 2024. Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time and will deliver prepared remarks via webcast followed by a question-and-answer session. How to participate:To listen to the webcast, visit the Alto Ingredients website. To receive a number and unique PIN by email, register here. To dial directly twenty minutes prior to the scheduled call time, dial (833) 630-0017 domestically and (412) 317-1806 internationally. Please ask to join Alto Ingredients.The...

Continue reading

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Dubai Healthcare Authority Granted Insurance Reimbursement for Biomerica’s EZ Detect™ Colon Disease Screening TestEZ Detect™ is a simple FDA cleared 2-minute at-home test that detects early warning signs of colorectal cancer, the third most common cancer worldwide Aware® is an FDA cleared simple at-home device clinically tested to increase sensitivity in breast self-exams; about 80% of breast cancers are detected by women themselves noticing changes in their breasts First order placed for both Colon Disease and Breast screening productsIRVINE, Calif., April 29, 2024 (GLOBE NEWSWIRE) — Biomerica Inc. (Nasdaq: BMRA), is proud to announce a multi-year exclusive distribution agreement with one of the UAE’s most substantial healthcare conglomerates. This strategic alliance is set to revolutionize the accessibility...

Continue reading

Volt Lithium Announces US$1.5 Million Strategic Investment to Commence Field Operations in the Delaware Basin in Texas, USA

Not for distribution to United States newswire services or for dissemination in the United States. CALGARY, Alberta, April 29, 2024 (GLOBE NEWSWIRE) — Volt Lithium Corp. (TSXV: VLT | OTCQB: VLTLF) (“Volt” or the “Company”) is pleased to announce a strategic investment of US$1,500,000 (the “Strategic Investment”) by a company (the “Investor”) with operations in the Delaware Basin in West Texas, USA, for the deployment of a field unit. This field unit will produce lithium hydroxide monohydrate using Volt’s proprietary direct lithium extraction (“DLE”) technology, building on the work done to date by Volt at the Company’s permanent Demonstration Plant in Calgary, Alberta. “We are very pleased to be collaborating with this operator to deploy Volt’s field unit in the Delaware Basin.” commented Volt’s President & CEO, Alex Wylie....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.